Cepheid Receives FDA Clearance for Xpert® Hemorrhagic Fever Panel Test
New multiplex PCR test simultaneously detects Ebola, Marburg, Lassa and Crimean-Congo hemorrhagic fever viruses in approximately 61 minutes. SUNNYVALE, Calif., Nov. 3, 2026 /PRNewswire/ -- Cepheid, a Danaher operating company, today announced that the U.S. Food and Drug Administration...
Covered in this story
Call it yourself
No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NOV →Dalsna Finance is currently tracking 117 stories mentioning NOV, the earliest published 26 Oct 2026.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.